Moonlake Immunotherapeutics Ag
Clinical trials sponsored by Moonlake Immunotherapeutics Ag, explained in plain language.
-
New shot could ease painful skin condition
Disease control CompletedThis study tested a drug called sonelokimab, given as a shot under the skin, in 422 adults with moderate to severe hidradenitis suppurativa (a painful skin condition causing boils and abscesses). Participants were randomly assigned to receive either the drug or a placebo for up t…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New shot could ease painful skin condition
Disease control CompletedThis study tested a drug called sonelokimab in 418 adults with moderate to severe hidradenitis suppurativa, a skin condition that causes painful lumps and abscesses. Participants received either the drug or a placebo injection for 16 weeks. The goal was to see if sonelokimab redu…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Autoinjector vs. syringe: which delivers sonelokimab better?
Knowledge-focused CompletedThis study in 120 healthy adults compared two methods of giving a single dose of sonelokimab: a prefilled syringe and an autoinjector. The goal was to see if both methods deliver the same amount of drug into the body. Researchers measured drug levels in the blood and checked for …
Phase: PHASE1 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC